83086-55-9Relevant articles and documents
Scaling-out pharmaceutical reactions in an automated stop-flow microwave reactor
Moseley, Jonathan D.,Woodman, Emily K.
, p. 967 - 981 (2008)
Six pharmaceutically relevant reactions were assessed for scaleout in an automated stop-flow microwave reactor. Daily throughputs of between 50 and 250 g were achieved at typical reaction concentrations; for more concentrated reactions, or with 24 h proce
(2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
-
, (2008/06/13)
The present invention relates to a series of (2-aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives which are useful as antifungal and antineoplastic agents.